Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Unusual clinical course of Graves' thyrotoxicosis and concomitant sarcoidosis: case report and review of literature.

Rodriguez MC, Rani D, Faas FH.

Endocr Pract. 2007 Mar-Apr;13(2):159-63. Review.

PMID:
17490930
2.

Resistant thyrotoxicosis: A case of sarcoidosis of thyroid.

Yanamandra U, Kotwal N, Menon A, Nair V.

Indian J Endocrinol Metab. 2013 Mar;17(2):332-5. doi: 10.4103/2230-8210.109662.

3.

A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland.

Zimmermann-Belsing T, Christensen L, Hansen HS, Kirkegaard J, Blichert-Toft M, Feldt-Rasmussen U.

Thyroid. 2000 Mar;10(3):275-8.

PMID:
10779143
4.

The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.

Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T.

Clin Endocrinol (Oxf). 1997 Oct;47(4):425-30.

PMID:
9404440
5.

Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.

Cunha FM, Rodrigues E, Oliveira J, Saavedra A, Vinhas LS, Carvalho D.

J Med Case Rep. 2016 Mar 31;10:70. doi: 10.1186/s13256-016-0878-7.

6.

Two cases of thyroid sarcoidosis presentation as painful, recurrent goiter in patients with Graves' disease.

Kmieć P, Lewandowska M, Dubaniewicz A, Mizan-Gross K, Antolak A, Wołyniak B, Sworczak K.

Arq Bras Endocrinol Metabol. 2012 Apr;56(3):209-14.

7.

Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.

Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.

Clin Invest Med. 1999 Aug;22(4):132-9.

PMID:
10497711
8.

[Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].

Jukić T, Stanicić J, Petric V, Kusić Z.

Lijec Vjesn. 2010 Nov-Dec;132(11-12):355-60. Croatian.

PMID:
21294325
9.

Treatment outcome of Graves' disease in Thai children.

Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P.

J Med Assoc Thai. 2007 Sep;90(9):1815-20.

PMID:
17957924
10.

Minimal change nephropathy and graves' disease: report of a case and review of the literature.

Tanwani LK, Lohano V, Broadstone VL, Mokshagundam SP.

Endocr Pract. 2002 Jan-Feb;8(1):40-3. Review.

PMID:
11939758
11.

Thyroid hemiagenesis associated with Graves' disease and Graves' ophthalmopathy: case report.

Ozgen AG, Saygili F, Kabalak T.

Thyroid. 2004 Jan;14(1):75-7.

PMID:
15009918
12.

Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.

Berg GE, Michanek AM, Holmberg EC, Fink M.

J Nucl Med. 1996 Feb;37(2):228-32.

13.

Graves' disease in the cervical thyroid and thyroglossal duct remnant: case report and review of literature.

Buckingham H, Sauerwein TJ, Golding AC.

Endocr Pract. 2006 Jul-Aug;12(4):401-5.

PMID:
16901795
14.

Hyperthyroidism: diagnosis and management of Graves' disease.

Schilling JS.

Nurse Pract. 1997 Jun;22(6):72, 75, 78 passim; quiz 96-7. Review.

PMID:
9211454
15.

Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.

Koornstra JJ, Kerstens MN, Hoving J, Visscher KJ, Schade JH, Gort HB, Leemhuis MP.

Neth J Med. 1999 Nov;55(5):215-21.

PMID:
10593131
16.

Treatment of Graves' hyperthyroidism--prognostic factors for outcome.

Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA.

Saudi Med J. 2007 Feb;28(2):225-30.

PMID:
17268701
18.

[Clinical aspects, diagnosis and drug therapy of hyperthyroidism].

Bürgi U, Gerber H, Peter HJ.

Schweiz Med Wochenschr. 1995 Aug 8;125(31-32):1489-94. German.

PMID:
7545825
19.

Hyperthyroidism. Current treatment guidelines.

Gittoes NJ, Franklyn JA.

Drugs. 1998 Apr;55(4):543-53. Review.

PMID:
9561343
20.

Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia.

Rahman MA, Birrell G, Stewart H, Lucraft H, Cheetham TD.

Arch Dis Child. 2003 Feb;88(2):158-9.

Supplemental Content

Support Center